291
Views
1
CrossRef citations to date
0
Altmetric
Original Research

High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics

, BSc, , MSc, , PhD, , , PhD & , PhDORCID Icon

References

  • Walker ER, Pratt LA, Schoenborn CA, Druss BG. Excess mortality among people who report lifetime use of illegal drugs in the United States: a 20-year follow-up of a nationally representative survey. Drug Alcohol Depend. 2017;171:31–38.
  • Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: Office of the Surgeon General; 2016.
  • Chitwood D, McBride DC, Metsch LR, Comerford M, McCoy CB. A comparison of the need for health care and use of health care by injection-drug users, other chronic drug users, and nondrug users. Am Behav Sci. 1998;41(8):1107–1122.
  • McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36(6–7):789–804.
  • Centre for Addiction and Mental Health. Mental Health and Primary Care Policy Framework. https://www.camh.ca/-/media/files/pdfs—public-policy-submissions/primarycarepolicyframework_march2016-pdf. Published 2016.
  • Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94–102.
  • Saitz R, Daaleman TP. Now is the time to address substance use disorders in primary care. Ann Fam Med. 2017;15(4):306–308.
  • Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286(14):1715–1723.
  • Korownyk C, Perry D, Ton J, et al. Managing opioid use disorder in primary care. Can Fam Physician. 2019;65(5):321–330.,
  • McGovern MP, Xie H, Segal SR, Siembab L, Drake RE. Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers. J Subst Abuse Treat. 2006;31(3):267–275.
  • Parthasarathy S, Mertens J, Moore C, Weisner C. Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care. 2003;41(3):357–367.
  • Gordon AJ, Drexler K, Hawkins EJ, et al. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Subst Abus. 2020;41(3):275–282.
  • Vancouver Coastal Health. The 2nd generation strategy. http://dtes.vch.ca/secondgenerationstrategy/. Published 2018.
  • Linden IA, Mar MY, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood-the vancouver downtown eastside from 2001 to 2011. J Urban Health. 2013;90(3):559–573.
  • OECD. Universal health coverage and health outcomes. https://www.oecd.org/els/health-systems/Universal-Health-Coverage-and-Health-Outcomes-OECD-G7-Health-Ministerial-2016.pdf. Published 2016.
  • Substance Abuse and Mental Health Services Adminstration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health; 2018. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf
  • Al-Tayyib AA, Thiede H, Burt RD, Koester S. Unmet health care needs and hepatitis C infection among persons who inject drugs in denver and seattle. Prev Sci. 2015;16(2):330–340.
  • Stein MD, Friedmann P. Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance. Am J Addict. 2002;11(4):262–270.
  • McKnight C, Shumway M, Masson CL, et al. Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethn Subst Abuse. 2017;16(4):404–419.
  • van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.
  • Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2–3):188–196.
  • Lim S, Harris TG, Nash D, Lennon MC, Thorpe LE. All-cause, drug-related, and hiv-related mortality risk by trajectories of jail incarceration and homelessness among adults in New York City. Am J Epidemiol. 2015;181(4):261–270.
  • Lambdin BH, Comfort M, Kral AH, Lorvick J. Accumulation of jail incarceration and hardship, health status, and unmet health care need among women who use drugs. Womens Health Issues. 2018;28(5):470–475.
  • Milloy MJ, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–1221.
  • Olding M, Hayashi K, Pearce L, et al. Developing a patient-reported experience questionnaire with and for people who use drugs: a community engagement process in Vancouver’s Downtown Eastside. Int J Drug Policy. 2018;59:16–23.
  • Wood E, Kerr T, Marshall BDL, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338(1):b1649–b1194.
  • Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB. Advances in patient-reported outcomes: the NIH PROMIS® measures. EGEMS. 2013;1(1):1015.
  • Merskey H. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain. 1986;3:S1–S226.
  • Hayashi K, Milloy M-J, Lysyshyn M, et al. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study. Drug Alcohol Depend. 2018;183:1–6.
  • Statistics Canada. Has a regular healthcare provider, by age group. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009616. Accessed February 28, 2020.
  • Neil B, Campbell L, Culbert L. A Thousand Dreams: Vancouver’s Downtown Eastside and the Fight for Its Future. Vancouver, Canada: D&M; 2010.
  • Vancouver Coastal Health. New clinic and new model of care on the DTES. http://dtes.vch.ca/2018/01/22/new-clinic-and-new-model-of-care-on-dtes/. Published 2018. Accessed February 16, 2020.
  • McCreaddie M, Lyons I, Watt D, et al. Routines and rituals: a grounded theory of the pain management of drug users in acute care settings. J Clin Nurs. 2010;19(19–20):2730–2740.
  • Berg KM, Arnsten JH, Sacajiu G, Karasz A. Providers’ experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009;24(4):482–488.
  • Lebovits AH, Florence I, Bathina R, Hunko V, Fox MT, Bramble CY. Pain knowledge and attitudes of healthcare providers: practice characteristic differences. Clin J Pain. 1997;13(3):237–243.
  • Baldacchino A, Gilchrist G, Fleming R, Bannister J. Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addict Behav. 2010;35(3):270–272.
  • Voon P, Callon C, Nguyen P, et al. Denial of prescription analgesia among people who inject drugs in a Canadian setting. Drug Alcohol Rev. 2015;34(2):221–228.
  • Fibbi M, Silva K, Johnson K, Langer D, Lankenau SE. Denial of prescription opioids among young adults with histories of opioid misuse. Pain Med. 2012;13(8):1040–1048.
  • Brener L, von Hippel W, von Hippel C, Resnick I, Treloar C. Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug Alcohol Rev. 2010;29(5):491–497.
  • Shekarchizadeh H, Khami MR, Mohebbi SZ, Ekhtiari H, Virtanen JI. Oral health of drug abusers: a review of health effects and care. Iran J Public Health. 2013;42(9):929–940. https://pubmed.ncbi.nlm.nih.gov/26060654.
  • Radloff LS, The CES. D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
  • Napper LE, Fisher DG, Johnson ME, Wood MM. The reliability and validity of drug users’ self reports of amphetamine use among primarily heroin and cocaine users. Addict Behav. 2010;35(4):350–354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.